PATENT CLAIM ANALYSIS

Application Number: 15904103
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "654000"]

Abstract:
A method of treating prostate cancer in a subject with biochemically recurrent prostate cancer is provided. The method includes administering to a subject in need thereof an effective amount of a pharmaceutical composition that includes phenelzine.

Claim (Index 6):
The method of  claim 1 , wherein a primary endpoint is a proportion of patients who achieve a PSA decline of \u226550% from baseline.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13559431', '15293055', '14615416', '11884568', '13623861']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7603517524405468
- 35 USC 102 Novelty (BERT): 0.5293450264908842
- Combined Prediction Score: 0.7372510798455805
- Mean Citation Score: 206.730264
- Max Citation Score: 245.91116
- Similarity Product: 107.93240003591536

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test